Key facts
- MiLaboratories’s last known valuation is $35.5M.
- It has raised $12.4M; the latest was Early Stage VC ($10.0M) in Oct 2024.
- Notable investors include Speedinvest, KFund, Acrobator Ventures, Bio, Courtyard Ventures — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for MiLaboratories
- ·The full record, as it builds
Funding rounds
No funding rounds for MiLaboratories are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MiLaboratories
Developer of medical imaging software designed to develop software for advanced bioinformatics tools for analyzing complex immune sequencing data. The company's software offers experiment planning, preparation of samples, sequencing to data processing, and extracting clinically relevant features and diagnostic patterns, enabling clinicians and researchers to identify similarities between immunology sequencing data and develop autoimmune disease drugs.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 21
- Website
- milaboratories.com/
- Ownership
- Privately Held (backing)
MiLaboratories doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MiLaboratories shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MiLaboratories in its N-PORT filings yet. We sweep new filings monthly.